B cell depletion in autoimmune rheumatic diseases

被引：21
|
作者：
Pitashny, M
Shoenfeld, Y
机构：
[1] Chaim Sheba Med Ctr, Dept Internal Med B, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[4] Tel Aviv Univ, Incumbent Laura Schwarz Kipp Chair Res Autoimmune, IL-69978 Tel Aviv, Israel
来源：
AUTOIMMUNITY REVIEWS | 2005年 / 4卷 / 07期
关键词：
anti-CD20; rituximab; autoimmune diseases; B cell depletion;
D O I：
10.1016/j.autrev.2005.03.002
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Rituximab is a chimeric mouse-human monoclonal antibody, which binds to CD20, a B cell surface marker, leading to cell death by complement induced lysis and apoptosis. Since the introduction of this drug in the treatment of non-Hodgkin lymphoma, its applications have been extended to autoimmune diseases. This review summarizes the actual possible uses of this novel immune system targeted drug, and explains the mechanism of B cell depletion in autoimmune diseases. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码：436 / 441
页数：6
相关论文
共 50 条
  • [31] Alterations In Circulating T Follicular Helper Cells and T Regulatory Cells In Autoimmune Rheumatic Diseases Treated With B Cell Depletion Therapy: Rituximab
    Lutalo, Pamela M. K.
    Zhao, Yuan
    Choong, Lee Meng
    Sangle, Shirish
    Spencer, Jo
    D'Cruz, David P.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S697 - S698
  • [32] Rheumatic Diseases and Autoimmune Diseases in the Pediatrics
    Hansen, G.
    MONATSSCHRIFT KINDERHEILKUNDE, 2018, 166 (07) : 560 - 561
  • [33] Interference of B lymphocyte tolerance by prolactin in rheumatic autoimmune diseases
    Mousavi, Mohammad Javad
    Alizadeh, Ardalan
    Ghotloo, Somayeh
    HELIYON, 2023, 9 (06)
  • [34] ALTERATIONS IN CIRCULATING T FOLLICULAR HELPER CELLS AND T REGULATORY CELLS IN AUTOIMMUNE RHEUMATIC DISEASES TREATED WITH B-CELL DEPLETION THERAPY: RITUXIMAB
    Lutalo, Pamela M.
    Zhao, Yuan
    Choong, Lee Meng
    Sangle, Shirish
    Spencer, Jo
    D'Cruz, David
    RHEUMATOLOGY, 2013, 52 : 136 - 136
  • [35] Iatrogenic antibody deficiency from B-cell targeted therapies in autoimmune rheumatic diseases
    Wijetilleka, Sonali
    Jayne, David
    Mukhtyar, Chetan
    Karim, Mohammed Yousuf
    LUPUS SCIENCE & MEDICINE, 2019, 6 (01):
  • [36] Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases
    Wijetilleka, Sonali
    Jayne, David R.
    Mukhtyar, Chetan
    Ala, Aftab
    Bright, Philip D.
    Chinoy, Hector
    Harper, Lorraine
    Kazmi, Majid A.
    Kiani-Alikhan, Sorena
    Li, Charles K.
    Misbah, Siraj A.
    Oni, Louise
    Price-Kuehne, Fiona E.
    Salama, Alan D.
    Workman, Sarita
    Wrench, David
    Karim, Mohammed Yousuf
    RHEUMATOLOGY, 2019, 58 (05) : 889 - 896
  • [37] Autoimmune rheumatic diseases and cancer
    Casciola-Rosen, Livia
    Shah, Ami
    Rosen, Antony
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [38] AUTOIMMUNE RHEUMATIC DISEASES AND OSTEOPOROSIS
    Athanassiou, P.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S102 - S102
  • [39] Neopterin in autoimmune rheumatic diseases
    Nassonov, EL
    Samsonov, MY
    Wirleitner, B
    Tilz, GP
    Fuchs, D
    PTERIDINES, 1999, 10 (03) : 119 - 124
  • [40] AUTOIMMUNE REACTIONS IN RHEUMATIC DISEASES
    MAERKERALZER, G
    INTERNIST, 1990, 31 (01): : 19 - 25
12345